Trial Profile
Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for age-related macular degeneration
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 19 Sep 2015 New trial record